Folia Histochemica et Cytobiologica 2012-01-01

Protein C activation peptide inhibits the expression of ICAM-1, VCAM-1, and interleukin-8 induced by TNF-α in human dermal microvascular endothelial cells.

María Del Socorro Pina-Canseco, Araceli Páez-Arenas, Felipe Massó, Eduardo Pérez-Campos, Ruth Martínez-Cruz, Pedro Hernández-Cruz, Abraham Majluf-Cruz, Margarito Martínez-Cruz, Laura Pérez-Campos Mayoral, Alma Dolores Pérez-Santiago, Edgar Zenteno

文献索引：Folia Histochem. Cytobiol. 50 , 407-13, (2012)

全文：HTML全文

摘要

Activated protein C (APC) is generated from the cleavage of protein C by thrombin coupled to thrombomodulin and, subsequently, is released as protein C activation peptide (papC). The aim of this study was to evaluate the effect of papC on human dermal microvascular endothelial cells (HMEC-1), activated with 5 ng//mL TNF-α. Flow cytometry showed that papC inhibited the expression of VCAM-1 and ICAM-1, after activation with TNF-a. Similarly, RT-PCR analysis revealed that 2 and 4 pM papC inhibited the expression of VCAM-1 and IL-8 mRNA in TNF-α-treated HMEC-1. In addition, the expression of endothelial nitric oxide synthase(eNOS) increased in HMEC-1 treated with papC, compared to those without treatment. Furthermore, Jurkat cell adhesion to HMEC-1 induced by TNF-a was significantly inhibited after the addition of papC, compared to HMEC-1 without papC (p = 0.03). Finally, a control peptide analog to papC showed no effect on the expression of ICAM and VCAM on the surface of HMEC-1. In conclusion, our results suggest that papC exerts anti-inflammatory effects on endothelial cells.